drugset / Trial / NCT00506935
Assessment of GVG for the Treatment of Methamphetamine Dependence
Phase 1
Completed
17 enrolled
Baylor College of Medicine
University of California, Los Angeles · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to find out if GVG can reduce drug use and determine safety and effects of GVG when used together with methamphetamine. This study involves staying in the hospital for 21 days. Participants will receive either placebo or GVG, and a limited amount if methamphetamine will be injected on some study days. This study will enroll people that use methamphetamine. Participants will be compensated.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-04
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GVG | Unknown | 5 g | — |